(Q34752291)

English

Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances ap

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

retracted paper

2 references

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances ap (English)

1 reference

Europe PubMed Central

4 August 2017

object named as

Gautam Sethi

2

0 references

author name string

Yasunari Takada

1

1 reference

Europe PubMed Central

4 August 2017

Bokyung Sung

3

1 reference

Europe PubMed Central

4 August 2017

Bharat B Aggarwal

4

1 reference

Europe PubMed Central

4 August 2017

publication date

20 February 2008

1 reference

Europe PubMed Central

4 August 2017

Molecular Pharmacology

1 reference

Europe PubMed Central

4 August 2017

73

1 reference

Europe PubMed Central

4 August 2017

5

1 reference

Europe PubMed Central

4 August 2017

1549-1557

1 reference

Europe PubMed Central

4 August 2017

AP-1 function and regulation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

AP-1 as a regulator of cell life and death

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Preclinical and clinical development of cyclin-dependent kinase modulators

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

An antiinflammatory cum immunomodulatory piperidinylbenzopyranone from dysoxylum binectariferum : isolation, structure and total synthesis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

PI-3K and Akt are mediators of AP-1 induction by 5-MCDE in mouse epidermal Cl41 cells

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

c-Jun and JunB antagonistically control cytokine-regulated mesenchymal-epidermal interaction in skin

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Common DNA binding site for Fos protein complexesand transcription factor AP-1

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Signalling pathways of the TNF superfamily: a double-edged sword

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

TNF-induced signaling in apoptosis

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Potent inhibition of CDC2 kinase activity by the flavonoid L86-8275.

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Tumor necrosis factor induces Bcl-2 and Bcl-x expression through NFkappaB activation in primary hippocampal neurons

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Nuclear factor-kappaB: its role in health and disease

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Alteration of the phosphorylation state of p34cdc2 kinase by the flavone L86-8275 in breast carcinoma cells. Correlation with decreased H1 kinase activity

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Synergistic induction of apoptosis in human myeloid leukemia cells by phorbol 12-myristate 13-acetate and flavopiridol proceeds via activation of both the intrinsic and tumor necrosis factor-mediated extrinsic cell death pathways

1 reference

9 February 2024

https://opencitations.net/index/api/v1/references/10.1124/MOL.107.041350

Identifiers

10.1124/MOL.107.041350

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34752291&oldid=2073025711"